MDRO – Orris AI

MDRO

Reading File

Finding Sources

Searching PubMed

multidrug-resistant organisms

Searching the Web

CDC multidrug-resistant organisms MDRO definition examples infection control

MDRO means multidrug-resistant organism: usually a bacterium resistant to one or more antimicrobial drug classes, making treatment options limited.

Common examples:

MRSA: methicillin-resistant Staphylococcus aureus
VRE: vancomycin-resistant Enterococcus
ESBL-producing Enterobacterales: resistant to many penicillins and cephalosporins
CRE/CPE: carbapenem-resistant or carbapenemase-producing Enterobacterales
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii

MDROs may cause the same syndromes as susceptible bacteria, but require culture and susceptibility-guided therapy. In healthcare settings, prevention includes hand hygiene, appropriate antimicrobial use, environmental cleaning, and precautions based on local infection-control policy. The CDC MDRO guidance defines MDROs and outlines their management.

A recent systematic review of infection-control interventions is indexed as PMID 40095361.

Under this topic, give me one specific topic which has literature review notes

Reading File

Finding Sources

Searching PubMed

multidrug-resistant organisms infection control

Searching the Web

multidrug-resistant organisms infection prevention control systematic review hospital CDC

Specific literature review topic

“Effectiveness of infection prevention and control bundles in reducing transmission of multidrug-resistant organisms in intensive care units.”

Why this is a good topic:
It is focused, clinically relevant, and has sufficient published evidence on MDROs such as MRSA, VRE, CRE, ESBL-producing Enterobacterales, Acinetobacter, and Pseudomonas.

Literature review notes

Background: MDRO transmission in ICUs is promoted by invasive devices, frequent antibiotic exposure, prolonged admission, critically ill patients, and close patient-healthcare worker contact.
Core interventions in an IPC bundle:
1. Hand hygiene adherence
2. Contact precautions and use of personal protective equipment
3. Active surveillance cultures or screening in selected high-risk settings
4. Environmental cleaning and disinfection of high-touch surfaces
5. Antimicrobial stewardship
6. Staff education, audit, and feedback
7. Decolonization in selected settings and organisms, particularly MRSA
Evidence summary: A 2025 systematic review and network meta-analysis evaluated infection-prevention measures for MDROs, supporting the use of combined approaches rather than relying on a single intervention (PMID 40095361). Evidence from outbreak-focused review literature also supports bundled infection-control measures in high-risk units, though studies differ substantially in their design and outcomes.
Key finding: Multimodal interventions tend to be more effective than isolated measures because they address transmission through hands, equipment, surfaces, inappropriate antimicrobial exposure, and unrecognized colonization simultaneously.
Limitations of the literature: Studies often use different MDRO definitions, bundle components, surveillance methods, and outcome measures. This makes direct comparison difficult and limits certainty about which individual bundle element has the greatest independent effect.
Conclusion: Infection-prevention bundles, integrated with antimicrobial stewardship and local surveillance, are the preferred approach for limiting ICU MDRO colonization and infection. The CDC prevention guidance identifies surveillance, Standard and Contact Precautions, environmental measures, education, decolonization, and judicious antimicrobial use as major control categories.

Give me reference also

Reading File

Reading Article

PMID: 40095361

Searching PubMed

intensive care unit multidrug-resistant organisms infection control

Searching the Web

CDC MDRO prevention control guideline citation 2006 2024

References

Geng, Y., Liu, Z., Ma, X., Pan, T., Chen, M., & Dang, J. (2025). Infection prevention and control measures for multidrug-resistant organisms: A systematic review and network meta-analysis. Infection. https://doi.org/10.1007/s15010-025-02498-9. See the PubMed record.
Centers for Disease Control and Prevention. (2006). Management of multidrug-resistant organisms in healthcare settings, 2006. The CDC prevention and control guidance covers surveillance, contact precautions, hand hygiene, environmental control, antimicrobial stewardship, education, and decolonization.
Heath, M. R., Fan, W., Leu, C.-S., et al. (2024). Gut colonization with multidrug resistant organisms in the intensive care unit: A systematic review and meta-analysis. Critical Care, 28, 307. https://doi.org/10.1186/s13054-024-04999-9. Available through PubMed.
Wang, C., Zhang, F., & Breland, A. (2021). Efficacy of infection control measures in managing outbreaks of multidrug-resistant organisms in burn units. Annals of Plastic Surgery, 86(Suppl 1), S60-S67. https://doi.org/10.1097/SAP.0000000000002825. See the PubMed entry.
Centers for Disease Control and Prevention. (2024). MDRO prevention strategies. The CDC prevention strategy addresses prevention of targeted MDROs, including carbapenemase-producing Enterobacterales, Pseudomonas, Acinetobacter, and Candida auris.

Now main topic is AI and digital health, give me one specific topic under it

Reading File

Finding Sources

Searching PubMed

artificial intelligence digital health clinical decision support

Searching the Web

WHO ethics governance artificial intelligence health digital health clinical decision support

Specific literature review topic

“Artificial intelligence-based clinical decision support systems for early detection and management of sepsis in hospital settings.”

This is a focused topic under AI and digital health with ample literature on machine-learning prediction models, electronic health-record alerts, clinical outcomes, clinician trust, algorithm bias, alert fatigue, privacy, and implementation barriers.

It can be reviewed under these headings:

AI models used for sepsis prediction
EHR integration and real-time alert systems
Impact on time to antibiotics, ICU admission, mortality, and length of stay
Challenges: false alerts, bias, explainability, and clinician acceptance
Ethical governance and patient-data privacy

The WHO guidance on AI ethics and governance provides a useful framework for discussing safety, accountability, equity, and data protection in this topic.

Reference also

Reading File

Searching PubMed

sepsis artificial intelligence clinical decision support

Searching the Web

sepsis machine learning clinical decision support systematic review PubMed

Finding Sources

Reading Article

PMID: 37172264

Reading Article

PMID: 33878596

Reading Article

PMID: 38269656

References

van der Vegt, A. H., Scott, I. A., Dermawan, K., Schnetler, R. J., Kalke, V. R., & Lane, P. J. (2023). Deployment of machine learning algorithms to predict sepsis: Systematic review and application of the SALIENT clinical AI implementation framework. Journal of the American Medical Informatics Association, 30(7), 1349-1361. https://doi.org/10.1093/jamia/ocad075. See the PubMed record.
Hassan, N., Slight, R., Weiand, D., Vellinga, A., Morgan, G., & Aboushareb, F. (2021). Preventing sepsis: How can artificial intelligence inform the clinical decision-making process? A systematic review. International Journal of Medical Informatics, 153, 104457. https://doi.org/10.1016/j.ijmedinf.2021.104457. See the PubMed record.
Ackermann, K., Westbrook, J. I., & Li, L. (2024). Usability of clinical decision support for adult sepsis detection. Studies in Health Technology and Informatics. https://doi.org/10.3233/SHTI231204. See the PubMed record.
Wu, M., et al. (2021). Artificial intelligence for clinical decision support in sepsis. Frontiers in Medicine, 8, 665464. https://doi.org/10.3389/fmed.2021.665464. Full text is available through PubMed Central.
World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. World Health Organization. The WHO guidance is useful for discussing data privacy, bias, transparency, safety, accountability, and human oversight.

Is that ai topic applicable in bhuta

Reading File

Searching the Web

Bhutan artificial intelligence digital health sepsis electronic health records hospital

Searching PubMed

Bhutan sepsis artificial intelligence

Finding Sources

Yes, it is applicable in Bhutan, but it should be framed as a feasibility and implementation topic, not as an intervention already proven in Bhutan.

There is no clear published evidence that AI-based sepsis prediction is currently deployed routinely in Bhutanese hospitals. However, Bhutan has been developing digital-health infrastructure, including electronic patient information systems, electronic medical records, and interoperable health-information systems. This makes AI-supported sepsis alerts a relevant future direction, particularly for referral hospitals.

A more suitable Bhutan-specific topic is:

“Readiness, opportunities, and barriers for implementing artificial intelligence-based sepsis early-warning systems in Bhutanese hospitals.”

Possible review areas:

Availability and quality of electronic patient data
Digital infrastructure and internet connectivity, especially outside urban hospitals
Workforce training and clinician acceptance
Validation of AI models using Bhutanese patient data
Patient privacy, data governance, and ethical oversight
Cost, maintenance, and integration into existing hospital workflows

Bhutan’s digital-health strategy has aimed to strengthen electronic medical records and connected health information systems, providing a foundation for such a future system. See Bhutan’s digital health strategy. The WHO also provides principles for safe, equitable, and accountable AI adoption in health through its AI ethics guidance.

For your literature review, do not claim that AI sepsis systems are already used in Bhutan unless you find local primary evidence. Instead, assess whether implementing them is realistic and what conditions are required.

NCP on Cholelithiasis

Reading File

Finding Sources

Searching PubMed

cholelithiasis nursing care perioperative

Searching the Web

NICE gallstone disease diagnosis management cholecystectomy guidance

Nursing Care Plan (NCP): Cholelithiasis

Medical diagnosis: Cholelithiasis (gallstones)
Common manifestations: Right upper-quadrant or epigastric pain, often after fatty meals; nausea, vomiting, dyspepsia, bloating, and possible fever or jaundice if complications develop.

Adapt this plan to the patient’s assessment findings, laboratory results, prescribed treatment, and whether the patient is preoperative or postoperative.

Assessment findings	Nursing diagnosis	Goals / expected outcomes	Nursing interventions	Rationale	Evaluation
Reports RUQ pain, may radiate to right shoulder or back; guarding, restlessness, pain after meals	Acute Pain related to biliary colic, gallbladder spasm, or inflammation secondary to gallstones as evidenced by verbal pain report and guarding	Within 30-60 minutes of intervention, patient reports pain reduced to a tolerable level, for example 3/10 or less; appears relaxed and can rest.	1. Assess pain location, severity, character, radiation, duration, precipitating factors, and associated symptoms using a pain scale. 2. Monitor vital signs and observe for guarding, diaphoresis, and restlessness. 3. Maintain NPO status during acute severe symptoms if prescribed. 4. Position for comfort, such as semi-Fowler's or side-lying with knees flexed. 5. Administer prescribed analgesics and antispasmodics; reassess effect and adverse effects. 6. Avoid high-fat foods when oral intake is permitted. 7. Report sudden worsening pain, fever, hypotension, persistent vomiting, jaundice, or abdominal rigidity.	Ongoing assessment identifies deterioration and measures treatment response. NPO status may reduce gallbladder stimulation. Analgesia promotes comfort and rest. Fatty meals stimulate gallbladder contraction and may precipitate biliary colic. New or worsening symptoms may suggest acute cholecystitis, cholangitis, pancreatitis, or obstruction.	Patient reports reduced pain, rests comfortably, has stable vital signs, and shows no signs of complications.
Nausea, vomiting, poor appetite, dehydration risk, reduced oral intake	Nausea related to biliary irritation and pain secondary to cholelithiasis	Within 24 hours, patient reports decreased nausea, has no or reduced vomiting, and maintains adequate hydration.	1. Assess nausea intensity, vomiting frequency, amount, and appearance. 2. Monitor intake and output; observe for dehydration such as dry mucosa, tachycardia, or reduced urine output. 3. Maintain NPO status or advance diet as prescribed. 4. Administer antiemetics as prescribed and evaluate response. 5. Provide oral care after vomiting. 6. When tolerated, introduce small, frequent, low-fat meals and encourage adequate fluids if not restricted.	Vomiting can lead to fluid and electrolyte imbalance. Antiemetics reduce nausea and facilitate intake. Gradual low-fat intake may reduce gallbladder contraction and symptoms. Oral care improves comfort and reduces unpleasant taste.	Patient has minimal or no vomiting, reports nausea relief, and has adequate urine output and hydration.
Limited understanding of disease, dietary needs, investigations, surgery, or medication regimen	Deficient Knowledge related to unfamiliarity with cholelithiasis, treatment plan, and prevention of symptom recurrence	Before discharge, patient and family explain the disease, prescribed treatment, diet advice, warning signs, and follow-up plan.	1. Assess current knowledge, health literacy, concerns, and readiness to learn. 2. Explain simply that gallstones are hardened deposits in the gallbladder that can obstruct bile flow and cause pain or complications. 3. Teach the purpose of tests such as abdominal ultrasound, liver function tests, complete blood count, and other investigations ordered. 4. Teach medication name, dose, purpose, schedule, and common adverse effects. 5. Advise a balanced, low-fat diet during symptomatic periods: avoid fried foods, fatty meat, full-fat dairy products, and large heavy meals. 6. Encourage regular meals, gradual weight loss if indicated, adequate fluids, and activity as tolerated. 7. Explain that symptomatic gallstones are commonly managed by laparoscopic cholecystectomy, according to clinician assessment. 8. Teach urgent warning signs: fever or chills, persistent severe pain, jaundice, dark urine, pale stool, repeated vomiting, confusion, or faintness.	Individual teaching improves adherence. Recognizing warning signs enables timely treatment of possible biliary obstruction or infection. For symptomatic gallbladder stones, laparoscopic cholecystectomy is commonly recommended, while asymptomatic gallstones generally do not need treatment. The NICE gallstone guideline supports these principles.	Patient accurately describes diet and medication instructions, identifies danger signs, and states the plan for follow-up or surgery.
Patient scheduled for laparoscopic cholecystectomy; may show worry about anesthesia, pain, or outcome	Anxiety related to hospitalization, pain, uncertainty, and anticipated surgery	Patient verbalizes reduced anxiety, asks relevant questions, and participates in treatment decisions.	1. Assess anxiety level and specific fears. 2. Encourage the patient to express concerns and ask questions. 3. Provide clear, consistent, factual information about the planned procedure and expected recovery. 4. Involve family or support person with consent. 5. Teach slow breathing, relaxation, or other preferred coping methods. 6. Administer prescribed anxiolytics if required and monitor response.	Accurate information and emotional support reduce uncertainty and improve coping. Relaxation techniques may reduce physiological effects of anxiety.	Patient appears calmer, verbalizes understanding, and participates in preoperative preparation.
If postoperative: incisional discomfort, anesthesia effects, limited mobility, risk of atelectasis and infection	Risk for Infection related to surgical incision and invasive procedures	Patient remains afebrile, wound stays clean and dry, and there is no purulent drainage, increasing redness, or wound separation.	1. Monitor temperature, pulse, wound appearance, dressing, and drainage. 2. Use aseptic technique for wound and IV care. 3. Encourage hand hygiene for patient, family, and staff. 4. Administer prescribed antibiotics if indicated. 5. Encourage early ambulation, coughing, deep breathing, and incentive spirometry if ordered. 6. Teach wound care and signs requiring medical review after discharge.	Early identification and prevention measures reduce postoperative wound and respiratory complications.	No fever or wound infection; patient demonstrates correct wound-care instructions.

Brief nursing notes

Diet: During symptomatic episodes, a low-fat diet and smaller frequent meals may reduce pain episodes. Strict long-term restriction is not always necessary after successful cholecystectomy unless otherwise advised.
Preoperative care: Confirm NPO status, allergies, consent according to local policy, laboratory reports, IV access, prescribed medications, and patient education.
Postoperative care: Monitor pain, vital signs, nausea, wound sites, ambulation, respiratory status, urine output, and tolerance of oral intake.
Urgent escalation: Notify the medical/surgical team for fever, jaundice, severe persistent pain, hypotension, altered mental status, vomiting that prevents hydration, or signs of sepsis.

Symptomatic cholelithiasis is commonly treated with laparoscopic cholecystectomy, whereas most asymptomatic gallstones are observed unless specific indications exist. This is consistent with the NICE recommendations.

This is a shared conversation. Sign in to Orris to start your own chat.